What GNE finds in Glycomed

Genentech Inc. hasn't been bashful about pulling the trigger on projects it doesn't intend to pursue, so its decision to renew its research collaboration with Glycomed Inc. for four years instead of two stands out as a vote of confidence in GLYC's carbohydrate technology.

Over the years, GNE has learned to make decisions quickly about projects, whether in-house or external, said Nicholas Simon, head of business development who negotiated the deal with GLYC.

"We have a value judgement - are the resources we're expending at

Read the full 849 word article

How to gain access

Continue reading with a
two-week free trial.